The reports on how to stimulate the ovaries for oocyte retrieval in good prognosis patients are contradictory and often favor one type of controlled ovarian hyperstimulation (COH). For this reason, we retrospectively analyzed data from IVF/ICSI cycles carried out at our IVF Unit in good prognosis patients (aged <38 years, first and second attempts of IVF/ICSI, more than 3 oocytes retrieved) to elucidate which type of COH is optimal at our condition. The included patients were undergoing COH using GnRH agonist, GnRH antagonist or GnRH antagonist mild protocol in combination with gonadotrophins. We found significant differences in the average number of retrieved oocytes, immature oocytes, fertilized oocytes, embryos, transferred embryos, embr...
AbstractFinal oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with ...
textabstractExtending the FSH window for multifollicular development by administering FSH from...
Objective: The use of GnRH antagonist versus GnRH agonist in poor responder for patient undergoing o...
Copyright © 2015 Martin Stimpfel et al.This is an open access article distributed under the Creative...
BACKGROUND: During IVF or ICSI cycles, ovarian hyperstimulation syndrome (OHSS) is a major problem. ...
WOS: 000399405200004Purpose: The aim of this study was to compare GnRH agonist long protocol and fle...
To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovar...
To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovar...
Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for various patient ...
OBJECTIVE: To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed ...
Implantation and live birth rates resulting from IVF cycles using gonadotropin-releasing hormone (Gn...
<div><p>Objective</p><p>To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist...
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a...
Extending the FSH window for multifollicular development by administering FSH from the midfollicular...
BACKGROUND: Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for vari...
AbstractFinal oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with ...
textabstractExtending the FSH window for multifollicular development by administering FSH from...
Objective: The use of GnRH antagonist versus GnRH agonist in poor responder for patient undergoing o...
Copyright © 2015 Martin Stimpfel et al.This is an open access article distributed under the Creative...
BACKGROUND: During IVF or ICSI cycles, ovarian hyperstimulation syndrome (OHSS) is a major problem. ...
WOS: 000399405200004Purpose: The aim of this study was to compare GnRH agonist long protocol and fle...
To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovar...
To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed normal ovar...
Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for various patient ...
OBJECTIVE: To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist in supposed ...
Implantation and live birth rates resulting from IVF cycles using gonadotropin-releasing hormone (Gn...
<div><p>Objective</p><p>To evaluate the effectiveness and safety of GnRH antagonist and GnRH agonist...
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a...
Extending the FSH window for multifollicular development by administering FSH from the midfollicular...
BACKGROUND: Most reviews of IVF ovarian stimulation protocols have insufficiently accounted for vari...
AbstractFinal oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with ...
textabstractExtending the FSH window for multifollicular development by administering FSH from...
Objective: The use of GnRH antagonist versus GnRH agonist in poor responder for patient undergoing o...